個案總覽

Spreadsheet for product 9B15N011.

Arun Kumar, founder and group chief executive officer of Strides Arcolab Limited — a first generation, Indian pharmaceutical company headquartered in Bengaluru — is preparing for a crucial meeting of the Board of Directors. The meeting was called to discuss the proposed dividend payout to the company’s shareholders following the completion of a US$1.725 billion sale of its specialty division — Agila Specialties — to the U.S.-based pharmaceutical company Mylan Inc. Kumar proposed that Strides distribute all the free cash available from the sale — after the retirement of debt and internal payouts — in the form of dividends to its shareholders. Strides had already communicated its decision to retire debts and reduce its leverage.

Arun Kumar, founder and group chief executive officer of Strides Arcolab Limited - a first generation, Indian pharmaceutical company headquartered in Bengaluru - is preparing for a crucial meeting of the Board of Directors. The meeting was called to discuss the proposed dividend payout to the company's shareholders following the completion of a US$1.725 billion sale of its specialty division - Agila Specialties - to the U.S.-based pharmaceutical company Mylan Inc. Kumar proposed that Strides distribute all the free cash available from the sale - after the retirement of debt and internal payouts - in the form of dividends to its shareholders. Strides had already communicated its decision to retire debts and reduce its leverage.

Arun Kumar, founder and group chief executive officer of Strides Arcolab Limited - a first generation, Indian pharmaceutical company headquartered in Bengaluru - is preparing for a crucial meeting of the Board of Directors. The meeting was called to discuss the proposed dividend payout to the company's shareholders following the completion of a US$1.725 billion sale of its specialty division - Agila Specialties - to the U.S.-based pharmaceutical company Mylan Inc. Kumar proposed that Strides distribute all the free cash available from the sale - after the retirement of debt and internal payouts - in the form of dividends to its shareholders. Strides had already communicated its decision to retire debts and reduce its leverage.

Spreadsheet for product 5B15N011.